Flash echo gray scale imaging with subtraction in assessment of small hepatocellular carcinoma treated with percutaneous ethanol injection: Preliminary report

Journal of Ultrasound in Medicine

Volumn 20, Issue 5, 2001, Pages 539-544

  Wang, Jing Houng ^a   Lu, Sheng Nan ^a   Changchien, Chi Sin ^a   Lee, Chuan Mo ^a   Tung, Hung Da ^a   Chen, Tsung Ming ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Flash echo imaging; Percutaneous ethanol injection; Small hepatocellular carcinoma

Indexed keywords

ANGIOGRAPHY; COMPUTERIZED TOMOGRAPHY; ETHANOL; MAGNETIC RESONANCE; TUMORS;

MICROBUBBLE CONTRAST AGENTS;

MEDICAL APPLICATIONS;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DIAGNOSTIC IMAGING; FEMALE; GRAY SCALE ECHOGRAPHY; HUMAN; LIVER ANGIOGRAPHY; LIVER BLOOD FLOW; LIVER CELL CARCINOMA; MALE; TREATMENT OUTCOME;

EID: 0035030405     PISSN: 02784297     EISSN: None     Source Type: Journal    
DOI: 10.7863/jum.2001.20.5.539     Document Type: Article

References (18)

1. Castells A, Bruix J, Bru C, et al. Treatment of small hepatocellular carcinoma in cirrhotic patients: a cohort study comparing surgical resection and percutaneous ethanol injection. Hepatology 1993; 18:1121-1126.
2. Livraghi T, Giorgio A, Marin G, et al. Hepatocellular carcinoma and cirrhosis in 746 patients: long term results of percutaneous ethanol injection. Radiology 1995; 197:101-108.
3. Schlief R. Developments in echo-enhancing agents. Clin Radiol 1996; 51(suppl 1):5-7.
4. Cosgrove DO, Blomley MJK, Jayaram V, et al. Echo-enhancing (contrast) agents. Ultrasound Q 1998; 14:66-75.
5. Burns PN. Harmonic imaging with ultrasound contrast agents. Clin Radiol 1996; 51(suppl 1):50-55.
6. Kamiyama N, Moriyasu F, Mine Y et al. Analysis of flash echo from contrast agent for designing optimal ultrasound diagnostic system. Ultrasound Med Biol 1998; 25:411-420.
7. Okuda K. Hepatocellular carcinoma: recent progress. Hepatology 1992; 15:948-963.
8. Lencioni R, Carmella D, Bartolozzi C. Hepatocellular carcinoma: use of color Doppler US to evaluate response to treatment with percutaneous ethanol injection. Radiology 1995; 194:113-118.
9. Shimamoto K, Sakuma S, Ishigaki T, et al. Hepatocellular carcinoma: evaluation with color Doppler US and MR imaging. Radiology 1992; 182:149-153.
10. Fujimoto M, Moriyasu F, Nishikawa K, et al. Color Doppler sonography of hepatic tumors with a galactose-based contrast agent: correlation with angiographic findings. AJR Am J Roentgenol 1994; 163:1099-1104.
11. Leen E, McArdle CS. Ultrasound contrast agents in liver imaging. Clin Radiol 1996; 51(suppl 1):35-39.
12. Bartolozzi C, Lencioni R, Ricci P, et al. Hepatocellular carcinoma treatment with percutaneous ethanol injection: evaluation with contrast-enhanced color Doppler US. Radiology 1998; 209:387-393.
13. Catalano O, Esposito M, Lobianco R, et al. Hepatocellular carcinoma treated with chemoembolization: assessment with contrast-enhanced Doppler ultrasound. Cardiovasc Intervent Radiol 1999; 22:486-492
14. Solbiati L, Goldgerg SN, Ierace T, et al. Radio-frequency ablation of hepatic metastases: postprocedural assessment with a US microbubble contrast agent - early experience. Radiology 1999; 211: 643-649.
15. Tanaka S, Kitamra T, Yoshioka F, et al. Effectiveness of galactose-based intravenous contrast medium on color Doppler sonography of deeply local hepatocellular carcinoma. Ultrasound Med Biol 1995; 21:157-160.
16. Choi BI, Kim TK, Han JK, et al. Power versus conventional color Doppler sonography: comparison in the depiction of vasculature in liver tumors. Radiology 1996; 200:55-58.
17. Kim AY, Choi BI, Kim TK, et al. Hepatocellular carcinoma: power Doppler US with a contrast agent -preliminary results. Radiology 1998; 209:135-140.
18. Moriyasu F, Kono Y, Nada T, et al. Flash echo (passive cavitation) imaging of the liver by using US contrast agents and intermittent scanning sequence [abstract]. Radiology 1996; 201(P):196.